Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rockwell Medical Projects Net Sales To Grow In The Mid-to-high Single Digits In 2025 And Beyond, And Gross Margin In 2025 To Be Approximately 20% And Reaching Above 25% In 2026 And Beyond

Author: Benzinga Newsdesk | August 08, 2024 06:05am

GUIDANCE

Rockwell Medical updates its 2024 guidance as follows:

 Updated 

2024 Guidance 

(As of August 8, 2024)		Updated 

2024 Guidance 

(As of May 14, 2024)		Original 

2024 Guidance 

(As of March 21, 2024)
Net (Product) Sales$95.0M to $98.0M$90.0M to $94.0M$84.0M to $88.0M
Gross Profit$14.0M to $16.0M$13.0M to $15.0M$12.0M to $14.0M
Gross Margin14% to 17%14% to 16%14% to 16%
Adjusted EBITDA$0.75M to $1.5M$0.5M to $1.0M$0M to $0.5M

Posted In: RMTI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist